Br J Pharmacol
From Bioblast
Revision as of 18:04, 22 March 2017 by Bitschnau Barbara (talk | contribs)
Journal title and website | British Journal of Pharmacology |
---|
Publications
Reference | Published | View | |
---|---|---|---|
Liepinsh 2024 Br J Pharmacol | Liepinsh E, Zvejniece L, Clemensson L, Ozola M, Vavers E, Cirule H, Korzh S, Skuja S, Groma V, Briviba M, Grinberga S, Liu W, Olszewski P, Gentreau M, Fredriksson R, Dambrova M, Schiรถth HB (2024) Hydroxymethylglutaryl-CoA reductase activity is essential for mitochondrial ฮฒ-oxidation of fatty acids to prevent lethal accumulation of long-chain acylcarnitines in the mouse liver. Br J Pharmacol [Epub ahead of print]. https://doi.org/10.1111/bph.16363 | 2024 | PMID: 38641905 Open Access |
Wu 2018 Br J Pharmacol | Wu C, Chen J, Yang R, Duan F, Li S, Chen X (2018) Mitochondrial protective effect of neferine through the modulation of nuclear factor erythroid 2-related factor 2 signalling in ischaemic stroke. Br J Pharmacol 176:400-15. | 2018 | PMID: 30414381 |
Cumero 2012 Br J Pharmacol | Cumero S, Fogolari F, Domenis R, Zucchi R, Mavelli I, Contessi S (2012) F0F1-ATPsynthase as a molecular target of 3-Iodothyronamine. Br J Pharmacol 166:2331-47 | 2012 | PMID: 22452346 |
Sanchez 2001 Br J Pharmacol | Sanchez H, Zoll J, Bigard X, Veksler V, Mettauer B, Lampert E, Lonsdorfer J, Ventura-Clapier R (2001) Effect of cyclosporin A and its vehicle on cardiac and skeletal muscle mitochondria: relationship to efficacy of the respiratory chain. Br J Pharmacol 133:781-8. https://doi.org/10.1038/sj.bjp.0704129 | 2001 | PMID: 11454650 Open Access |
Satoh 1995 Br J Pharmacol | Satoh K, Yamato A, Nakai T, Hoshi K, Ichihara K (1995) Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in ischaemic dog hearts. Br J Pharmacol 116:1894-98. | 1995 | PMID:8528576 |